Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 3900

1.

Smallpox vaccination and adverse reactions. Guidance for clinicians.

Cono J, Casey CG, Bell DM; Centers for Disease Control and Prevention.

MMWR Recomm Rep. 2003 Feb 21;52(RR-4):1-28.

2.

Recommendations for using smallpox vaccine in a pre-event vaccination program. Supplemental recommendations of the Advisory Committee on Immunization Practices (ACIP) and the Healthcare Infection Control Practices Advisory Committee (HICPAC).

Wharton M, Strikas RA, Harpaz R, Rotz LD, Schwartz B, Casey CG, Pearson ML, Anderson LJ; Advisory Committee on Immunization Practices; Healthcare Infection Control Practices Advisory Committee.

MMWR Recomm Rep. 2003 Apr 4;52(RR-7):1-16.

3.

Smallpox vaccination reactions, prophylaxis, and therapy of complications.

Goldstein JA, Neff JM, Lane JM, Koplan JP.

Pediatrics. 1975 Mar;55(3):342-7. Review.

PMID:
238178
4.

Ocular complications in the Department of Defense Smallpox Vaccination Program.

Fillmore GL, Ward TP, Bower KS, Dudenhoefer EJ, Grabenstein JD, Berry GK, Madigan WP Jr.

Ophthalmology. 2004 Nov;111(11):2086-93.

PMID:
15522376
5.

Smallpox vaccine: contraindications, administration, and adverse reactions.

Maurer DM, Harrington B, Lane JM.

Am Fam Physician. 2003 Sep 1;68(5):889-96. Review.

6.

Surveillance guidelines for smallpox vaccine (vaccinia) adverse reactions.

Casey C, Vellozzi C, Mootrey GT, Chapman LE, McCauley M, Roper MH, Damon I, Swerdlow DL; Vaccinia Case Definition Development Working Group; Advisory Committee on Immunization Practices-Armed Forces Epidemiological Board Smallpox Vaccine Safety Working Group.

MMWR Recomm Rep. 2006 Feb 3;55(RR-1):1-16.

7.

Severe eczema vaccinatum in a household contact of a smallpox vaccinee.

Vora S, Damon I, Fulginiti V, Weber SG, Kahana M, Stein SL, Gerber SI, Garcia-Houchins S, Lederman E, Hruby D, Collins L, Scott D, Thompson K, Barson JV, Regnery R, Hughes C, Daum RS, Li Y, Zhao H, Smith S, Braden Z, Karem K, Olson V, Davidson W, Trindade G, Bolken T, Jordan R, Tien D, Marcinak J.

Clin Infect Dis. 2008 May 15;46(10):1555-61. doi: 10.1086/587668.

8.

Eczematous skin disease and recall of past diagnoses: implications for smallpox vaccination.

Naleway AL, Belongia EA, Greenlee RT, Kieke BA Jr, Chen RT, Shay DK.

Ann Intern Med. 2003 Jul 1;139(1):1-7.

PMID:
12834312
9.

Clinical efficacy of intramuscular vaccinia immune globulin: a literature review.

Hopkins RJ, Lane JM.

Clin Infect Dis. 2004 Sep 15;39(6):819-26. Epub 2004 Aug 23. Review.

10.

Surveillance for safety after immunization: Vaccine Adverse Event Reporting System (VAERS)--United States, 1991-2001.

Zhou W, Pool V, Iskander JK, English-Bullard R, Ball R, Wise RP, Haber P, Pless RP, Mootrey G, Ellenberg SS, Braun MM, Chen RT.

MMWR Surveill Summ. 2003 Jan 24;52(1):1-24. Erratum in: MMWR Morb Mortal Wkly Rep. 2003 Feb 14;52(06):113.

11.

Extracorporeal photophoresis: an evidence-based analysis.

Health Quality Ontario.

Ont Health Technol Assess Ser. 2006;6(6):1-82. Epub 2006 Mar 1.

12.

Pregnancy discovered after smallpox vaccination: Is vaccinia immune globulin appropriate?

Napolitano PG, Ryan MA, Grabenstein JD.

Am J Obstet Gynecol. 2004 Dec;191(6):1863-7. Review.

PMID:
15592266
13.

Transmission of vaccinia virus, possibly through sexual contact, to a woman at high risk for adverse complications.

Said MA, Haile C, Palabindala V, Barker N, Myers R, Thompson R, Wilson L, Allan-Martinez F, Montgomery J, Monroe B, Tack D, Reynolds M, Damon I, Blythe D.

Mil Med. 2013 Dec;178(12):e1375-8. doi: 10.7205/MILMED-D-13-00233.

PMID:
24306023
14.

Pathogenesis and potential antiviral therapy of complications of smallpox vaccination.

Bray M.

Antiviral Res. 2003 Apr;58(2):101-14. Review.

PMID:
12742570
15.

Adverse events occurring after smallpox vaccination.

Lane JM, Goldstein J.

Semin Pediatr Infect Dis. 2003 Jul;14(3):189-95. Review.

PMID:
12913830
16.

Women with smallpox vaccine exposure during pregnancy reported to the National Smallpox Vaccine in Pregnancy Registry--United States, 2003.

Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2003 May 2;52(17):386-8.

17.

Clinical guidance for smallpox vaccine use in a postevent vaccination program.

Petersen BW, Damon IK, Pertowski CA, Meaney-Delman D, Guarnizo JT, Beigi RH, Edwards KM, Fisher MC, Frey SE, Lynfield R, Willoughby RE.

MMWR Recomm Rep. 2015 Feb 20;64(RR-02):1-26.

18.

Malaria surveillance--United States, 2009.

Mali S, Tan KR, Arguin PM; Division of Parasitic Diseases and Malaria, Center for Global Health; Centers for Disease Control and Prevention.

MMWR Surveill Summ. 2011 Apr 22;60(3):1-15.

19.

Postexposure prevention of progressive vaccinia in SCID mice treated with vaccinia immune globulin.

Fisher RW, Reed JL, Snoy PJ, Mikolajczyk MG, Bray M, Scott DE, Kennedy MC.

Clin Vaccine Immunol. 2011 Jan;18(1):67-74. doi: 10.1128/CVI.00280-10. Epub 2010 Nov 24.

20.

Ocular vaccinia following exposure to a smallpox vaccinee.

Hu G, Wang MJ, Miller MJ, Holland GN, Bruckner DA, Civen R, Bornstein LA, Mascola L, Lovett MA, Mondino BJ, Pegues DA.

Am J Ophthalmol. 2004 Mar;137(3):554-6.

PMID:
15013881
Items per page

Supplemental Content

Write to the Help Desk